REGULATION OF PLACENTAL VASCULAR REACTIVITY IN PIH
妊娠高血压综合征中胎盘血管反应性的调节
基本信息
- 批准号:3357072
- 负责人:
- 金额:$ 13.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-09-30 至 1992-07-31
- 项目状态:已结题
- 来源:
- 关键词:angiotensin II arachidonate dipyridamole eicosanoid metabolism embryo /fetus death embryo /fetus hypoxia embryo /fetus pharmacology embryo /fetus preservation high performance liquid chromatography hyperoxia hypocalcemia imidazole isomerase leukotrienes lipoxygenase magnesium deficiency norepinephrine peptidyl dipeptidase A perfusion placenta placental transfer pregnancy circulation pregnancy disorder chemotherapy pregnancy toxemia /hypertension prostacyclins prostaglandin analogs prostaglandin endoperoxide synthase pyrazoles radioimmunoassay renin angiotensin system reversed phase chromatography serotonin thromboxanes vascular resistance vasoactive agent vasoconstriction vasoconstrictors vasomotion
项目摘要
Pregnancy-induced hypertension (PIH) is associated with increased
fetal and neonatal morbidity and mortality possibly resulting from
hypoxia in utero. The primary pathology of PIH involves a
reduction in uteroplacental blood flow but modern imaging
techiques have now shown that increased impedance of the fetal-
placental circulation and hence reduced blood flow can also be
found in PIH. This may represent a direct effect of hypoxia or be
a fetal adaptation to increase placental oxygen extraction to
relieve hypoxia. The fetal-placental circulation is regulated by
humoral agents and vascular pressure. An imbalance of
vasodilator prostacyclin (PGI2) and vasoconstrictor thromboxane
(TxA2) production is reported to underlie the vasoconstriction
seen in PIH.
We will commence with the premise that there is an imbalance of
PGI2 and TxA2 in PIH. We will establish in the fetal-placental
circulation of the perfused human placental cotyledon from both
normotensive and PIH pregnancies:
1. If such an imbalance in PGI2/TxA2 production exists
2. Its relationship to the responses of the fetal-placental
circulation to vasoconstrictors
3. The effect of increasing fetal-placental flow on PGI2
production and responses to vasoconstrictors.
4. The effects of hypocalcemia and hypomagnesemia on PGI2
synthesis and if supplementation with these cations alters
responses to vasoconstrictors
5. If hypoxia reduces PGI2 synthesis or angiotensin converting
enzyme activity and so alters vascular reactivity
6. Whether there is an increase in lipoxygenase product
(leukotriene) formation linked to the deficiency in PGI2 synthesis
7. If drugs now used to restore the PGI2/TxA2 balance in PIH
may cross the placenta and alter umbilical vascular reactivity.
Our primary objective is to elucidate the potential role an
imbalance in PGI2/TxA2 may have in controlling the vascular
reactivity of the fetal/placental circulation, what the underlying
mechanisms are behind the PGI2/TxA2 imbalance and how
therapeutic agents may affect this to improve blood flow and
reduce fetal morbidity and mortality.
妊娠高血压综合征(PIH)与妊娠高血压相关。
胎儿和新生儿的发病率和死亡率可能由
子宫内缺氧 妊高征的主要病理包括
子宫胎盘血流减少,但现代成像
技术人员现在已经表明,胎儿的阻抗增加,
胎盘循环和因此减少的血流量也可以
在PIH中发现 这可能是缺氧的直接影响,
胎儿适应性增加胎盘氧摄取,
缓解缺氧。 胎儿-胎盘循环由
体液因子和血管压力。 的不平衡
血管扩张剂前列环素(PGI 2)和血管收缩剂血栓素
据报道,血栓素A2(TxA 2)的产生是血管收缩的基础。
在PIH中看到
我们将从这样一个前提开始:
PIH中的PGI 2和TxA 2。 我们将在胎儿胎盘中建立
人胎盘子叶的血液循环
正常血压和PIH妊娠:
1. 如果PGI 2/TxA 2产生存在这种不平衡,
2. 其与胎儿-胎盘反应的关系
血管收缩剂循环
3. 增加胎儿-胎盘血流对PGI_2的影响
产生和对血管收缩剂的反应。
4. 低钙、低镁血症对前列环素的影响
合成,如果补充这些阳离子改变
对血管收缩剂的反应
5. 如果缺氧减少PGI 2合成或血管紧张素转换
酶活性,从而改变血管反应性
6. 脂氧合酶产物是否增加
(白三烯)形成与PGI 2合成缺陷有关
7. 如果现在使用药物来恢复PIH中的PGI 2/TxA 2平衡,
可能穿过胎盘并改变脐血管反应性。
我们的主要目标是阐明潜在的作用,
PGI_2/TxA_2的失衡可能在控制血管紧张素转换酶活性方面起着重要作用。
胎儿/胎盘循环的反应性,
PGI 2/TxA 2失衡背后的机制以及如何
治疗剂可以影响这一点以改善血流,
降低胎儿发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLIE MYATT其他文献
LESLIE MYATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLIE MYATT', 18)}}的其他基金
Placental Mitochondrial Function in Gestational Diabetes
妊娠糖尿病中的胎盘线粒体功能
- 批准号:
10396015 - 财政年份:2018
- 资助金额:
$ 13.09万 - 项目类别:
Placental Mitochondrial Function in Gestational Diabetes
妊娠糖尿病中的胎盘线粒体功能
- 批准号:
9920017 - 财政年份:2018
- 资助金额:
$ 13.09万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
8707875 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
9353444 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8741981 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8650502 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8895208 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
9276325 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
8491926 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
相似海外基金
Elucidation of the anti-inflammatory mechanism of dexmedetomidine - Analysis of arachidonate metabolism -
右美托咪定抗炎机制阐明 - 花生四烯酸代谢分析 -
- 批准号:
15K20526 - 财政年份:2015
- 资助金额:
$ 13.09万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Regulation and role of the arachidonate cascade reaction at different life stages of adipocytes
脂肪细胞不同生命阶段花生四烯酸级联反应的调控及作用
- 批准号:
25450128 - 财政年份:2013
- 资助金额:
$ 13.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the treatment that targeted an arachidonate cascade of the oral cancer neighborhood environment
开发针对口腔癌邻近环境的花生四烯酸级联的治疗方法
- 批准号:
24593022 - 财政年份:2012
- 资助金额:
$ 13.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate-5-lipoxygenase
父母决定的口服孟鲁司特治疗学龄前喘息,并根据花生四烯酸 5 脂氧合酶分层
- 批准号:
MC_G1002451 - 财政年份:2010
- 资助金额:
$ 13.09万 - 项目类别:
Intramural
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia
精神分裂症中的磷脂-花生四烯酸-类二十烷酸信号传导
- 批准号:
8392108 - 财政年份:2009
- 资助金额:
$ 13.09万 - 项目类别:
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia
精神分裂症中的磷脂-花生四烯酸-类二十烷酸信号传导
- 批准号:
7906866 - 财政年份:2009
- 资助金额:
$ 13.09万 - 项目类别:
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia
精神分裂症中的磷脂-花生四烯酸-类二十烷酸信号传导
- 批准号:
7796483 - 财政年份:2009
- 资助金额:
$ 13.09万 - 项目类别:
Studies on novel mechanisms of environmental chemicals-induced toxicity using arachidonate-metabolizing enzyme genetically modified mice
利用花生四烯酸代谢酶转基因小鼠研究环境化学物质诱导毒性的新机制
- 批准号:
21390036 - 财政年份:2009
- 资助金额:
$ 13.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia
精神分裂症中的磷脂-花生四烯酸-类二十烷酸信号传导
- 批准号:
8195990 - 财政年份:2009
- 资助金额:
$ 13.09万 - 项目类别:
Effect of docosahexaenoate and arachidonate supplementation in rat pup intestinal immunity
补充二十二碳六烯酸和花生四烯酸对幼鼠肠道免疫的影响
- 批准号:
370255-2008 - 财政年份:2008
- 资助金额:
$ 13.09万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




